These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17851857)

  • 1. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
    Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
    J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
    Malila N; Anttila A; Hakama M
    J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 13. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
    Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
    J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.